Doctor profile · Federal record

Dr. Sudha Teerdhala, MD

Medical Oncology Physician (CMS: Medical Oncology) · Mesquite, TX

  • NPI 1700828548
  • Accepts Medicare
  • MIPS 86.7 / 100 · 2023
  • 39 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
4700 N Galloway Ave
Mesquite, TX 751501516
(972) 686-6411
fax (972) 686-0594
Mailing address
Po Box 911230
Dallas, TX 753911230

Credentials & registration

NPPES · NUCC
NPI registered
June 2006 — 20 yrs on file
Profile last updated
May 8, 2008
Year of graduation
1987 — 39 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State license (1)
Texas #K4266
Medicaid (2)
TX #040628201 · TX #101119902

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1700828548. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
34,804
Distinct HCPCS
10
Medicare allowed
$608,338
HCPCS Description Services Patients Avg allowed
J1756 Injection, iron sucrose, 1 mg 11,900 26 $0
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 6,630 11 $0
J9271 Injection, pembrolizumab, 1 mg 5,700 12 $55
J1453 Injection, fosaprepitant, 1 mg 4,350 13 $0
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 957 291 $8
36415 Insertion of needle into vein for collection of blood sample 859 262 $8
J1100 Injection, dexamethasone sodium phosphate, 1 mg 650 32 $0
80053 Blood test, comprehensive group of blood chemicals 556 268 $10
99214 Established patient office or other outpatient visit, 30-39 minutes 360 242 $123
J2469 Injection, palonosetron hcl, 25 mcg 340 17 $1

In context: peer comparison

Among 3 peers in this city , average services per provider: 899. This provider delivers 39× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,211
Transactions
43
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 11 $183.69
SOBI, INC 1 $99.99
Karyopharm Therapeutics Inc. 1 $98.92
Tempus AI, Inc 2 $94.50
ABBVIE INC. 5 $90.97
Merck Sharp & Dohme LLC 4 $78.24
Incyte Corporation 3 $70.04
Gilead Sciences, Inc. 3 $56.00
E.R. Squibb & Sons, L.L.C. 3 $52.38
Kite Pharma, Inc. 2 $45.32
PFIZER INC. 2 $44.38
GlaxoSmithKline, LLC. 2 $36.72
Lilly USA, LLC 2 $35.09
PharmaEssentia USA Corporation 1 $31.64
Celgene Corporation 1 $30.68

By nature of payment

Food and Beverage
$1,111
Education
$100

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
808
Patients
221
Total drug cost
$17,032
Drug Type Claims Patients Total cost
Anastrozole Generic 207 54 $5,236
Dexamethasone Generic 78 19 $1,423
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 69 34 $2,069
Potassium Chloride Generic 64 19 $1,166
Ondansetron Hcl Generic 51 14 $599
Gabapentin Generic 49 14 $513
Alendronate Sodium Generic 41 11 $371
Ciprofloxacin Hcl Generic 40 21 $264
Levothyroxine Sodium Generic 34 0 $376
Warfarin Sodium Generic 33 13 $485

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Sudha Teerdhala's medical specialty?
Dr. Sudha Teerdhala practices Medical Oncology Physician in Mesquite, TX.
Where does Dr. Sudha Teerdhala practice?
Dr. Sudha Teerdhala practices at 4700 N Galloway Ave, Mesquite, TX 751501516. Office phone: 9726866411.
What is Dr. Sudha Teerdhala's NPI?
Dr. Sudha Teerdhala's National Provider Identifier (NPI) is 1700828548, issued by NPPES.
Does Dr. Sudha Teerdhala accept Medicare assignment?
Yes. Dr. Sudha Teerdhala accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sudha Teerdhala commonly perform?
Top Medicare-reported procedures in 2023: Injection, iron sucrose, 1 mg (HCPCS J1756); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.